Quipt Home Medical Corp. announced its fourth quarter and fiscal year 2025 financial results, highlighting revenue growth and operational achievements.
The Company reported an 11% increase in revenue for Q4 2025 compared to the previous year, with strong organic growth.
Adjusted EBITDA for Q4 2025 also saw a significant increase of 11%, showcasing the Company's financial performance.
Revenue Growth
Q4 2025 revenue increased by 11% year-over-year, driven by strong organic growth.
Recurring Revenue
Recurring revenue in Q4 2025 accounted for 80% of total revenue, reflecting the success of the resupply platform.
Adjusted EBITDA
Adjusted EBITDA for Q4 2025 grew by 11% compared to the previous year, demonstrating improved financial performance.
Customer Base Expansion
The Company's customer base grew by 10% in fiscal year 2025, reaching 346,000 unique patients served.
Operational Efficiency
Technology and centralized processes led to a 7% increase in unique set-ups/deliveries in fiscal year 2025.
- The financial results for Q4 2025 and fiscal year 2025 highlight strong revenue growth and operational advancements for Quipt Home Medical Corp.
- The Company's focus on recurring revenue and operational efficiency has positively impacted its financial performance and customer base growth.
Quipt Home Medical Corp.'s financial results for Q4 and fiscal year 2025 reflect a successful year of growth and operational excellence in the home medical equipment sector.